Whole-Genome Draft Sequences of Nine Asymptomatic Escherichia coli Bacteriuria Isolates from Diabetic Patients by Stork, Christoph et al.
Whole-Genome Draft Sequences of Nine Asymptomatic
Escherichia coli Bacteriuria Isolates from Diabetic Patients
Christoph Stork,a Beáta Kovács,b,c Eva Trost,a* Tamás Kovács,d György Schneider,b Barnabás Rózsai,e Monika Kerényi,b
Levente Emődy,b Ulrich Dobrindta
aInstitute of Hygiene, University of Münster, Münster, Germany
bDepartment of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary
c1st Department of Medicine, University of Pécs, Pécs, Hungary
dNanophagetherapy Center, Enviroinvest Corp., Pécs, Hungary
eDepartment of Pediatrics, University of Pécs, Pécs, Hungary
ABSTRACT Escherichia coli can colonize the urinary bladder without causing a dis-
ease response in the host. This asymptomatic bacteriuria (ABU) can protect against
recurrent symptomatic urinary tract infection by virulent bacteria. Here, we report
the whole-genome sequences of nine E. coli ABU isolates from diabetic patients.
Urinary tract infection (UTI) constitutes a serious global health problem associatedwith considerable morbidity and death and can affect patient quality of life.
Symptomatic UTI is caused most often by Escherichia coli. Besides provoking symptoms,
E. coli can also asymptomatically colonize the human bladder for extended time
periods. Asymptomatic bacteriuria (ABU) does not, with some exceptions, require any
treatment (1). Deliberate colonization of the urinary bladder thus represents a prom-
ising alternative to antibiotic treatment and prevents colonization by more virulent
bacterial strains (2–4). To characterize bacterial traits that contribute to the fitness and
competitiveness of E. coli ABU strains in urine, we sequenced nine ABU isolates from
patients with diabetes mellitus in Hungary.
Total genomic DNA was isolated from the E. coli ABU isolates using the MagAttract
high-molecular-weight (HMW) DNA kit (Qiagen, Hilden, Germany). To prepare 500-bp
paired-end libraries of all ABU isolates, we used the Nextera XT DNA library preparation
kit (Illumina, San Diego, CA, USA). Libraries were sequenced on the Illumina MiSeq
sequencing platform using v2 sequencing chemistry. E. coli ABU isolate 65 was se-
quenced twice on the Illumina platform. In addition, this strain was subjected to
whole-genome bidirectional sequencing using the Roche GS Junior sequencer with
titanium chemistry (Roche Hungary Ltd., Budaörs, Hungary). E. coli ABU strain 65 reads
from the Illumina and Roche sequencing platforms were included in a hybrid assembly.
Prior to assembly, raw reads of all ABU isolates were quality checked with FastQC
(v11.5) (http://www.bioinformatics.babraham.ac.uk/projects/fastqc), and low-quality
reads were trimmed using Sickle (v1.33) (https://github.com/najoshi/sickle). Subse-
quently, the quality-filtered reads were de novo assembled using SPAdes (v3.9.0) (5).
Final genome assemblies were analyzed using QUAST (v4.3) (6), resulting in 43 to 197
contigs of 1 kb, and accounting for total genome sizes ranging from 4,578,015 to
5,285,335 bp (Table 1). Coding sequences (CDSs) and orthologous genes were deter-
mined using Prokka (v1.12) (7) and Proteinortho (v5.15) (8). Between 4,204 and 5,035
coding DNA sequences were identified in the corresponding genomes (Table 1). To
predict and identify plasmids, serotypes, and acquired antibiotic resistance mecha-
nisms, we performed a systematic analysis, querying the databases PlasmidFinder (v1.3)
(9), SerotypeFinder (v1.1) (10), and ResFinder (v2.1) (11), respectively. For the determi-
nation of virulence factors (VFs), we extended the freely available E. coli VF collection
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(v0.1) (https://doi.org/10.5281/zenodo.56686). Core genome multilocus sequence
typing (cgMLST) was performed with SeqSphere (v3.4.0) (Ridom GmbH, Münster,
Germany).
The draft genomes of nine clinical ABU isolates from diabetic patients will serve as a
useful source for upcoming comparative studies of E. coli isolate virulence- and
fitness-related traits that promote efficient growth and competitiveness in urine. The
identification of bacterial characteristics relevant for efficient and safe therapeutic
bladder colonization will improve the application of bacterial interference.
Accession number(s). The assembled draft genome sequences obtained from this
project were deposited into DDBJ/ENA/GenBank under the accession numbers listed in
Table 1.
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ABU 1 B1 (205) 11,310,408 8,774,314 43 4,578,015 236,117 8 285 4,204 PENN00000000
ABU 9 B2 (95) 10,142,410 7,982,006 106 5,212,357 220,362 7 228 4,862 PENO00000000
ABU 61 F (59) 6,927,866 3,800,294 197 5,183,452 55,491 28 158 4,888 PENP00000000




124 5,184,119 150,223 12 179,c 16d 5,035 PENQ00000000
ABU 84 B2 (73) 9,577,806 7,435,548 78 5,223,185 301,227 6 212 4,871 PENR00000000
ABU 91 B2 (95) 8,845,416 6,756,004 81 5,285,335 268,769 7 190 5,002 PENJ00000000
ABU 106 B2 (95) 1,220,066 774,552 108 4,939,518 129,842 10 33 4,601 PENK00000000
ABU 123 D (69) 6,759,080 2,783,684 96 4,917,555 115,220 13 116 4,547 PENL00000000
ABU 148 B2 (73) 9,488,588 7,435,092 87 5,154,177 248,638 7 214 4,795 PENM00000000
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